A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study

BACKGROUND: In premenopausal women, endocrine adjuvant therapy for breast cancer primarily consists of tamoxifen alone or with ovarian suppressive strategies. Toremifene is a chlorinated derivative of tamoxifen, but with a superior risk-benefit profile. In this retrospective study, we sought to esta...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Gu, Ran, Jia, Weijuan, Zeng, Yunjie, Rao, Nanyan, Hu, Yue, Li, Shunrong, Wu, Jiannan, Jin, Liang, Chen, Lijuan, Long, Meijun, Chen, Kai, Chen, Lili, Xiao, Qiaozhen, Wu, Mei, Song, Erwei, Su, Fengxi
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3503787/
https://ncbi.nlm.nih.gov/pubmed/22548922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-161
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items